Study of Cigarette Smoking on Haematological Parameters and Lipid Profile in Vidharbha Region, India

Abstract

Introduction: Cigarette smoke increases the risk of cardiovascular disease, such as coronary heart disease and peripheral vascular disease. Atherosclerosis, myocardial infarction, and stroke are also examples of ischaemic heart disease. Cigarette smoke contains more than 4,000 substances that have a negative or minimal effect on human health, including free radicals, nicotine, and the most important carbon monoxide in the pharmacy. Tobacco smoke kills 6 million people a year, many from lung cancer, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD). When opposed to never-smokers, smokers lose 10–15 years of life on average, and they begin to develop tobacco-related disorders such as coronary disease. Aim: Study of Cigarette Smoking on Haematological parameters and Lipid Profile in Vidharbha Region Material and Method: 25 subjects were smokers and 25 subjects were non-smokers. Patients went directly to the Observed Treatment Short-course focus in the Dept. of Medicine and Dept. of Respiratory, Datta Meghe Medical College and Shalinitai Meghe Hospital and Research Center. Result: Patients who were non-smokers and smokers were compared. Total cholesterol, triglycerides, LDL, and VLDL are statistically higher in smokers than non-smokers, but the same is true for HDL-cholesterol. Smokers had slightly lower HDL cholesterol than non-smokers. Conclusion: The smokers in this sample had dyslipidaemia as well as a large rise in haemoglobin and haematocrit. The RBC count rises as the rate of smoking rises, as it does in heavy smokers, and the altered lipid profile worsens. This dyslipidaemia in smokers can expose the vascular endothelium to potentially atherogenic lipoproteins, placing smokers at higher risk of developing atherosclerotic plaques and heart disease. As a result, quitting smoking early can alter these processes, which may prevent any major health risks.